allograft

(redirected from allograft rejection)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for allograft

tissue or organ transplanted from a donor of the same species but different genetic makeup

Synonyms

Related Words

References in periodicals archive ?
Banff schema for grading liver allograft rejection: an international consensus document.
TIM-3 is a type I membrane protein preferentially expressed on terminally differentiated Th1 cells that seems to be central in the mechanisms of allograft rejection (15).
It has been shown that miRNAs may be associated with allograft rejection, ischemia-reperfusion injury, and fibrosis after kidney and other solid organ transplantations.
Teraoka, "Lobular damage caused by cellular and humoral immunity in liver allograft rejection," Clinical Transplantation, vol.
In addition, the serum cortisol would not be expected to have any influence on the patient's propensity to experience allograft rejection. The data support the safety of discontinuing steroids for patients with an AM cortisol value of at least 8 ng/dL and the distribution of the cortisol measurements suggests that this is a good discriminator with very few patients near the cut point.
As transplant vasculopathy is a kind of allograft rejection, there is a need to investigate the effect of ERCs on the treatment of it.
Antretter et al., "B-type natriuretic peptide as a marker of allograft rejection after heart transplantation," The Journal of Heart and Lung Transplantation, vol.
Corneal allograft rejection is a delayed-type hypersensitivity reaction (DTH), and CD4+ T cells are the predominant cell type in this process.
Allograft rejection is a serious complication in lung transplant because of potential acute graft dysfunction or failure and/or subsequent complications that can lead to chronic graft failure.
Corneal allograft rejection is a multifaceted process that involves complex interactions between cells of innate and adaptive immunity.
The canonical variables originated from disease pathways including HTLV-I infection, herpes simplex infection, Epstein-Barr virus infection, viral carcinogenesis, viral myocarditis, type I diabetes mellitus, graft-versus-host disease, autoimmune thyroid disease, allograft rejection, pathways in cancer, influenza A, proteoglycans in cancer, tuberculosis, transcriptional misregulation in cancer, Huntington's disease, toxoplasmosis, hepatitis B, measles, microRNAs in cancer, hepatitis C, and Alzheimer's disease.
The principle challenge in kidney transplantation is the suppression of allograft rejection. Thus, use of immunosuppressive drugs (ID) is inevitable.
Pathology results "were reminiscent of those observed in patients with acute allograft rejection after cardiac transplantation," Dr.